SAFC to make virus-resistant cell lines

By Fiona Barry

- Last updated on GMT

Rodent droppings can introduce viruses into raw materials warehouses
Rodent droppings can introduce viruses into raw materials warehouses

Related tags: Cell lines, Cell culture

BioReliance and its parent company SAFC say they are working on viral-resistant cell lines that will prevent contamination in bioreactors.

Kevin Kayser, head of R&D at SAFC, told BioPharma-Reporter.com the viral safety of raw materials is “an area that’s really hot right now.”

He said the company is working to prevent the propagation of viruses that can affect mammalian cell lines as well as human pathogens, as opposed to the issue of viral clearance, which tackles the viruses later in the manufacturing process which can affect humans.   

Kayser told this publication the company had attained proof-of-principle on virus-resistant lines, but still had validation work to complete.

We don’t know what the end product looks like yet but we’ve certain manipulations within the cell that provide viral resistance. We’ve created some targets. The trick will ultimately be [showing] that you can confer in the CHO [Chinese hamster ovary] cell lines, but you can’t change anything else [such as] sugars.​”

‘Two-pronged’ attack

Commonly, viruses can enter cell culture raw materials from mice droppings in warehouses.  One particle that becomes incorporated can be reproduced as cell lines grow until they prove damaging or fatal for the cells.

Prevention should be a “two-pronged process,​” Kayser said, both screening raw materials to prevent contamination, and as a second line of defence, creating cell lines that will not propagate a virus if it reaches the bioreactor; “it’s a fairly rare event, but it’s an insurance policy.​”

Alison Armstrong, a senior director within Development Services at BioReliance told an SAFC symposium on biopharmaceutical supply chain vulnerability last week that viral risk “causes an enormous amount of impact to industry.”

Cell loss due to pathogens can slow manufacturing and impact the availability of medicines to patients, she said, “especially with life threatening diseases – this can have a direct effect on materials or products, which are [sometimes] produced by sole source providers.”

Armstrong also pointed out that, aside from cell death, the stress of infections can affect the quality of cells and “have a direct impact on post-translation modification​.”

She added that viral contamination brings additional risks to other products in the same facility, a situation BioReliance has been “directly impacted by.​”

Related news

Show more

Related products

show more

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 10-Feb-2021 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 10-Feb-2021 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Rapid Biosafety Testing Enables the Future of Manufacturing

Rapid Biosafety Testing Enables the Future of Manufacturing

Viral Safety for mAb: Prevent, Detect, Remove | 23-Nov-2020 | Technical / White Paper

This white paper explores the factors driving the evolution toward faster biosafety testing and describes rapid approaches for adventitious agent testing...

Related suppliers

Follow us

Products

View more

Webinars